Free Trial
NYSEAMERICAN:IBIO

iBio (IBIO) Stock Price, News & Analysis

$0.73 +0.00 (+0.14%)
As of 04:00 PM Eastern

About iBio Stock (NYSEAMERICAN:IBIO)

Key Stats

Today's Range
$0.72
$0.73
50-Day Range
$0.71
$1.03
52-Week Range
$0.64
$6.89
Volume
680,372 shs
Average Volume
1.53 million shs
Market Capitalization
$2.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

iBio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

IBIO MarketRank™: 

iBio scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for iBio.

  • Percentage of Shares Shorted

    14.71% of the float of iBio has been sold short.
  • Short Interest Ratio / Days to Cover

    iBio has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iBio has recently increased by 171.74%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    iBio does not currently pay a dividend.

  • Dividend Growth

    iBio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.71% of the float of iBio has been sold short.
  • Short Interest Ratio / Days to Cover

    iBio has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iBio has recently increased by 171.74%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for iBio this week, compared to 0 articles on an average week.
  • Search Interest

    Only 2 people have searched for IBIO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iBio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.12% of the stock of iBio is held by insiders.

  • Percentage Held by Institutions

    Only 7.90% of the stock of iBio is held by institutions.

  • Read more about iBio's insider trading history.
Receive IBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iBio and its competitors with MarketBeat's FREE daily newsletter.

IBIO Stock News Headlines

Altucher: Trump’s Great Gain is starting
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.
iBio announces data from non-human primate PK study of IBIO-600
iBio to transfer listing to Nasdaq from NYSE
See More Headlines

IBIO Stock Analysis - Frequently Asked Questions

iBio's stock was trading at $2.42 at the start of the year. Since then, IBIO shares have decreased by 69.8% and is now trading at $0.7310.

Shares of IBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iBio investors own include Mesoblast (MESO), Mobileye Global (MBLY), KULR Technology Group (KULR), IonQ (IONQ), Guardforce AI (GFAI), Fastly (FSLY) and Exscientia (EXAI).

Company Calendar

Today
7/18/2025
Next Earnings (Estimated)
9/19/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:IBIO
CIK
1420720
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.01 million
Net Margins
N/A
Pretax Margin
-41,546.00%
Return on Equity
-150.59%
Return on Assets
-52.83%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
0.91
Quick Ratio
0.91

Sales & Book Value

Annual Sales
$2.38 million
Price / Sales
1.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$15.15 per share
Price / Book
0.05

Miscellaneous

Outstanding Shares
3,480,000
Free Float
3,445,000
Market Cap
$2.52 million
Optionable
N/A
Beta
-3.77
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSEAMERICAN:IBIO) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners